First U.S. implant at Cleveland Clinic signals another key shift away from transvenous leads
International study finds 94.6% success for scheduled transmissions, good patient acceptance
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy